You can buy or sell ASMB and other stocks, options, and ETFs commission-free!
Assembly Biosciences, Inc. Common Stock, also called Assembly Biosciences, is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. It focuses in two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics candidate. The company was founded by Uri Lopatin and Derek A. Small on October 7, 2005 and is headquartered in South San Francisco, CA. The listed name for ASMB is Assembly Biosciences, Inc. Common Stock.
John G. McHutchison
South San Francisco, California
52 Week High
52 Week Low
— per share
Expected Apr 5, After Hours